Roche Tocilizumab IP Relaxation Does Not Go Far Enough

MSF Says Non-Enforcement Of Actemra/RoActemra Patents Should Go Beyond LMICs

 
• By David Wallace
Tocilizumab injection Syringe
Roche has promised not to enforce tocilizumab patents in LMICs • Source: Alamy

More from Legal & IP

More from Generics Bulletin